Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy

References

• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
   PubMed Web of Science ®Google Scholar
• GeLWangYFTianJHNetwork meta-analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancerJ Clin Pharm Ther201641438339127338003
   PubMed Web of Science ®Google Scholar
• El KhouryFCorcosLDurandSSimonBLe Jossic-CorcosCAcquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cellsInt J Oncol20164962558256827748801
   PubMed Web of Science ®Google Scholar
• PerezMLucena-CacaceAMarín-GómezLMDasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-SrcOncotarget2016722331113312427105527
   PubMedGoogle Scholar
• KilicLOrduCYildizICurrent adjuvant treatment modalities for gastric cancer: from history to the futureWorld J Gastrointest Oncol20168543944927190583
   PubMed Web of Science ®Google Scholar
• GuoYXiongBHZhangTChengYMaLXELOX vs FOLFOX in metastatic colorectal cancer: an updated meta-analysisCancer Invest20163429410426864862
   PubMed Web of Science ®Google Scholar
• Di FranciaRSiestoRSValenteDCurrent strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel testsAnticancer Drugs201324101069107824025562
   PubMed Web of Science ®Google Scholar
• CvitkovicEBekraddaMOxaliplatin: a new therapeutic option in colorectal cancerSemin Oncol199926664766210606258
   PubMed Web of Science ®Google Scholar
• MissetJLBleibergHSutherlandWBekraddaMCvitkovicEOxaliplatin clinical activity: a reviewCrit Rev Oncol Hematol2000352759310936465
   PubMed Web of Science ®Google Scholar
• DilrubaSKalaydaGVPlatinum-based drugs: past, present and futureCancer Chemother Pharmacol20167761103112426886018
   PubMed Web of Science ®Google Scholar
• QuirogaDLyerlyHKMorseMADeficient mismatch repair and the role of immunotherapy in metastatic colorectal cancerCurr Treat Options Oncol20161784127315067
   PubMed Web of Science ®Google Scholar
• Da SilvaFCWernhoffPDominguez-BarreraCDominguez-ValentinMUpdate on hereditary colorectal cancerAnticancer Res20163694399440627630275
   PubMed Web of Science ®Google Scholar
• KapEJSeiboldPRichterSGenetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancerPharmacogenomics J201515650551225778469
   PubMed Web of Science ®Google Scholar
• McculloughLESantellaRMClevelandRJPolymorphisms in DNA repair genes, recreational physical activity and breast cancer riskInt J Cancer2014134365466323852586
   PubMed Web of Science ®Google Scholar
• CorralRLewingerJPvan den BergDComprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and ShanghaiInt J Cancer2014135233534724382701
   PubMed Web of Science ®Google Scholar
• LiuJSunLXuQAssociation of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risksOncotarget2016766972698326760766
   PubMedGoogle Scholar
• LiuJZhangZCaoXLXPA A23G polymorphism and susceptibility to cancer: a meta-analysisMol Biol Rep20123966791679922314912
   PubMed Web of Science ®Google Scholar
• ZouJHAnLChenSRenLQXPA A23G polymorphism and lung cancer risk: a meta-analysisMol Biol Rep20123921435144021611749
   PubMed Web of Science ®Google Scholar
• WangGSunHLiuZLack of associations between XPC polymorphisms and colorectal cancer: a meta-analysisJ Buon201520377077426214629
   PubMed Web of Science ®Google Scholar
• SankhwarMSankhwarSNBansalSKGuptaGRajenderSPolymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analysesSci Rep201662701827246180
   PubMed Web of Science ®Google Scholar
• ShiYHWangBXuBPThe association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysisJ Cell Mol Med201620112056206327306318
   PubMed Web of Science ®Google Scholar
• LoghinABănescuCNechifor-BoilaAXRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinomaCancer Biomark201616221121726682510
   PubMed Web of Science ®Google Scholar
• PichierriPAmmazzalorsoFBignamiMFranchittoAThe Werner syndrome protein: linking the replication checkpoint response to genome stabilityAging20113331131821389352
   PubMedGoogle Scholar
• ZinsKFrechBTaubenschussESchneebergerCAbrahamDSchreiberMAssociation of the rs1346044 polymorphism of the Werner syndrome gene RECQL2 with increased risk and premature onset of breast cancerInt J Mol Sci20151612296432965326690424
   PubMed Web of Science ®Google Scholar
• JiangSHuNZhouJPolymorphisms of the WRN gene and DNA damage of peripheral lymphocytes in age-related cataract in a Han Chinese populationAge20133562435244423334603
   PubMedGoogle Scholar
• EhrenbergMDratviman-StorobinskyOAvraham-LubinBRGoldenberg-CohenNLack of association of the WRN C1367T polymorphism with senile cataract in the Israeli populationMol Vis2010161771177520808731
   PubMed Web of Science ®Google Scholar
• FrankBHoffmeisterMKloppNIlligTChang-ClaudeJBrennerHColorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLMCarcinogenesis201031344244519945966
   PubMed Web of Science ®Google Scholar
• SugimotoYTsukaharaSIshikawaEMitsuhashiJBreast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamicsCancer Sci200596845746516108826
   PubMed Web of Science ®Google Scholar
• PollexEKAngerGHutsonJKorenGPiquette-MillerMBreast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphismDrug Metab Dispos201038574074420159988
   PubMed Web of Science ®Google Scholar
• NoguchiKKatayamaKMitsuhashiJSugimotoYFunctions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapyAdv Drug Deliv Rev2009611263319111841
   PubMed Web of Science ®Google Scholar
• OhtsukaKOhnishiHMoriiTDownregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancerJ Thorac Oncol20105111726173320975373
   PubMed Web of Science ®Google Scholar
• WenCCYeeSWLiangXGenome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseClin Pharmacol Ther201597551852525676789
   PubMed Web of Science ®Google Scholar
• WuHLiuYKangHGenetic variations in ABCG2 gene predict breast carcinoma susceptibility and clinical outcomes after treatment with anthracycline-based chemotherapyBiomed Res Int201520152791091226634205
   PubMed Web of Science ®Google Scholar
• KobayashiDIeiriIHirotaTFunctional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placentaDrug Metab Dispos20053319410115475413
   PubMed Web of Science ®Google Scholar
• BramEEIferganIGrimbergMLemkeKSkladanowskiAAssarafYGC421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cellsBiochem Pharmacol2007741415317481587
   PubMed Web of Science ®Google Scholar
• WuHKangHLiuYAssociation of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosisPharmacogenomics201314889791123746184
   PubMed Web of Science ®Google Scholar
• Perez-MayoralJPacheco-TorresALMoralesLAcosta-RodriguezHMattaJLDutilJGenetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican womenMol Carcinogen201352SupplE127E138
   PubMedGoogle Scholar
• ZhaoJLiWZhuDAssociation of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancerMed Oncol201431180224338217
   PubMed Web of Science ®Google Scholar
• MeiCHouMGuoSPolymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese peopleThorac Cancer20145323224226767006
   PubMed Web of Science ®Google Scholar
• RavegniniGNanniniMSimeonVPolymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcomeTumour Biol20163710134131342327460091
   PubMedGoogle Scholar
• WangBXuQYangHWSunLPYuanYThe association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer riskOncotarget2016715203572036726967386
   PubMedGoogle Scholar
• SunYTanLLiHQinXLiuJAssociation of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese populationInt J Clin Exp Pathol201589116151162126617899
   PubMed Web of Science ®Google Scholar
• ZhaoFShangYZengCGaoDLiKAssociation of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancerInt J Clin Exp Pathol201589115791158626617894
   PubMed Web of Science ®Google Scholar
• ChoiHYBaeKSChoSHImpact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acidPharmacogenet Genomics2015251259560826367500
   PubMed Web of Science ®Google Scholar
• CampaDPardiniBNaccaratiAA gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancerMutat Res20086451–2566018775442
   PubMed Web of Science ®Google Scholar
• OberstadtMCBien-MöllerSWeitmannKEpigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiformeBMC Cancer20131361724380367
   PubMed Web of Science ®Google Scholar
• HanWKimKYYangSJNohDYKangDKwackKSNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean populationCancer2012118359460221751184
   PubMed Web of Science ®Google Scholar
• TianCAmbrosoneCBDarcyKMCommon variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group studyGynecol Oncol2012124357558122112610
   PubMed Web of Science ®Google Scholar
• GaoCWangJLiCZhangWLiuGA Functional polymorphism (rs10817938) in the XPA promoter region is associated with poor prognosis of oral squamous cell carcinoma in a Chinese Han populationPLoS One2016119e016080127622501
   PubMed Web of Science ®Google Scholar
• WerbrouckEBastinJLambrechtsDABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinibActa Clin Belg Epub2018523
   Web of Science ®Google Scholar